Clear AllFeatured
February 12, 2026 | San Francisco, CA, USA
JIMCO Invests in Ever’s US$ 31m Series-A Funding Round
JIMCO invests in Ever’s US$31m Series-A round supporting Ever’s AI‑native, full-stack auto retail platform.
Technology
November 25, 2025 | Cambridge, MA, USA
JIMCO participates in Vertical Semiconductor’s $11m seed funding round
The JIMCO Technology Fund has participated in the seed funding round for Vertical Semiconductor, a developer of next-gen computing infrastructure tech
Technology
November 11, 2025 | San Francisco, USA
JIMCO participates in Starship’s US$ 50 million Series C funding round
JIMCO announces that the JIMCO Technology Fund participated in the US$ 50 million Series C funding round for Starship Technologies, a world leader in
Technology
December 13, 2024 | Dubai, UAE
Ziina US$ 22 million Series A funding round
JIMCO invests in fintech company Ziina in US$ 22 million Series A funding round
Technology
November 19, 2024 | Riyadh, Saudi Arabia
JIMCO invests in fintech Lean Technologies US$ 67.5m Series B round
JIMCO's participation in this round illustratives our commitment to drive greater financial inclusivity across the region.
Technology
October 17, 2022 | Dubai, UAE
JIMCO invests in Turkish fintech start-up Figopara in Series A round
JIMCO invests in Turkish fintech start-up Figopara in Series A funding round
Technology
August 23, 2022 | Dubai, UAE
JIMCO invests in biotech tissue engineering start-up VitroLabs
JIMCO invests in biotech start-up VitroLabs Inc to build and scale the world’s first pilot production of cell cultivated leather
Technology
January 6, 2022 | Vancouver, BC & Monaco
JIMCO major participation in US$ 130m funding round for General Fusion
JIMCO Technology Fund announces second major fusion energy investment, participating in US$ 130 million Series E funding round for General Fusion
Technology
December 11, 2021 | Cambridge, UK
JIMCO Life Sciences Fund participates in Cambridge Epigenetix US$ 88m
JIMCO Life Sciences Fund participates in Cambridge Epigenetix US$ 88m Series D round advancing best-in-class DNA sequencing technology platform
Life Sciences
